National Institute of Health: New clinical studies on long COVID therapies launched

The National Institutes of Health (NIH) in the USA announce the launch of new clinical studies. They do research on new therapies for the treatment of long COVID complaints. In the RECOVER-VITAL study, for example, a therapy with the drug Paxlovid is being researched. This is a possible therapeutic approach if SARS-CoV-2 viruses remain in the body even after the acute infection has ended. Another example is the RECOVER-NEURO study, in which therapies for impaired mental abilities are being researched, such as web-based training programmes. The RECOVER-SLEEP study aims to do research on possible therapies for sleep disturbances. Among other things, the RECOVER-AUTONOMIC study will do research on therapy for disorders of the circulatory system. A further study will focus on the treatment of stress intolerance and fatigue.

The studies are part of the NIH’s RECOVER (Researching COVID to Enhance Recovery) initiative. This is a national research programme in the USA. It aims to understand, prevent and treat long COVID. The following English-language website of the initiative provides extensive information about the programme:  https://recovercovid.org/